Ziqi Tan

608 total citations · 1 hit paper
15 papers, 351 citations indexed

About

Ziqi Tan is a scholar working on Cardiology and Cardiovascular Medicine, Infectious Diseases and Surgery. According to data from OpenAlex, Ziqi Tan has authored 15 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cardiology and Cardiovascular Medicine, 3 papers in Infectious Diseases and 3 papers in Surgery. Recurrent topics in Ziqi Tan's work include Cardiovascular Function and Risk Factors (4 papers), COVID-19 Clinical Research Studies (3 papers) and Parathyroid Disorders and Treatments (3 papers). Ziqi Tan is often cited by papers focused on Cardiovascular Function and Risk Factors (4 papers), COVID-19 Clinical Research Studies (3 papers) and Parathyroid Disorders and Treatments (3 papers). Ziqi Tan collaborates with scholars based in China, United States and Hong Kong. Ziqi Tan's co-authors include Jianyong Ma, Peng Yu, Menglu Liu, Xiao Liu, Huilei Zhao, Wengen Zhu, Jingfeng Wang, Yujie Zhao, Yuna Huang and Kui Hong and has published in prestigious journals such as Biomedicine & Pharmacotherapy, Frontiers in Endocrinology and Journal of the American Heart Association.

In The Last Decade

Ziqi Tan

12 papers receiving 350 citations

Hit Papers

Relationship between the ... 2022 2026 2023 2024 2022 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ziqi Tan China 10 148 137 93 50 41 15 351
Stylianos Daios Greece 11 173 1.2× 114 0.8× 64 0.7× 62 1.2× 32 0.8× 55 360
Huilei Zhao China 9 157 1.1× 143 1.0× 90 1.0× 46 0.9× 38 0.9× 16 342
Konstantinos Balampanis Greece 7 97 0.7× 129 0.9× 65 0.7× 58 1.2× 76 1.9× 18 367
Ferrán Rius Spain 13 82 0.6× 239 1.7× 46 0.5× 91 1.8× 40 1.0× 39 467
Kensuke Matsushita France 10 145 1.0× 71 0.5× 46 0.5× 63 1.3× 44 1.1× 32 349
Rosa Cannistraci Italy 12 75 0.5× 166 1.2× 194 2.1× 66 1.3× 43 1.0× 24 419
Damirbek Osmonov Türkiye 14 270 1.8× 66 0.5× 72 0.8× 95 1.9× 32 0.8× 35 445
Aharon Erez Israel 13 313 2.1× 94 0.7× 89 1.0× 148 3.0× 35 0.9× 23 493
Murat Şahin Türkiye 12 58 0.4× 82 0.6× 35 0.4× 71 1.4× 47 1.1× 52 334
Oana L. Klein United States 9 117 0.8× 62 0.5× 57 0.6× 40 0.8× 21 0.5× 15 374

Countries citing papers authored by Ziqi Tan

Since Specialization
Citations

This map shows the geographic impact of Ziqi Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ziqi Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ziqi Tan more than expected).

Fields of papers citing papers by Ziqi Tan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ziqi Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ziqi Tan. The network helps show where Ziqi Tan may publish in the future.

Co-authorship network of co-authors of Ziqi Tan

This figure shows the co-authorship network connecting the top 25 collaborators of Ziqi Tan. A scholar is included among the top collaborators of Ziqi Tan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ziqi Tan. Ziqi Tan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Yang, Yingying, Haochen Li, Peng Liu, et al.. (2025). Multitemporal single‐cell profiling uncovers alveolar IL1β hi neutrophils: A significant indicator of CARDS progression. Clinical and Translational Medicine. 15(10). e70479–e70479.
2.
Tan, Ziqi, Longxiang Su, Xiangyu Chen, Huaiwu He, & Yun Long. (2024). Relationship between the Pre-ECMO and ECMO Time and Survival of Severe COVID-19 Patients: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine. 13(3). 868–868.
3.
Zhao, Huilei, Ziqi Tan, Menglu Liu, et al.. (2023). Is There a Sex Difference in the Prognosis of Hypertrophic Cardiomyopathy? A Systematic Review and Meta‐Analysis. Journal of the American Heart Association. 12(11). e026270–e026270. 19 indexed citations
4.
Zhao, Huilei, Ziqi Tan, Jin Zhou, et al.. (2023). The regulation of circRNA and lncRNA protein binding in cardiovascular diseases: Emerging therapeutic targets. Biomedicine & Pharmacotherapy. 165. 115067–115067. 11 indexed citations
5.
Liu, Fuwei, Huilei Zhao, Ziqi Tan, et al.. (2023). Body mass index and atrial fibrillation recurrence post ablation: A systematic review and dose-response meta-analysis. Frontiers in Cardiovascular Medicine. 9. 999845–999845. 12 indexed citations
6.
Li, Xiaozhong, et al.. (2023). Prevalence estimates of the insulin resistance and associated prevalence of heart failure among United Status adults. BMC Cardiovascular Disorders. 23(1). 294–294. 21 indexed citations
7.
Liu, Menglu, Ziqi Tan, Shan Huang, et al.. (2022). Liver Fibrosis Scores and Hospitalization, Mechanical Ventilation, Severity, and Death in Patients with COVID-19: A Systematic Review and Dose-Response Meta-Analysis. Canadian Journal of Gastroenterology and Hepatology. 2022. 1–11. 15 indexed citations
8.
Liu, Xiao, Ziqi Tan, Yuna Huang, et al.. (2022). Relationship between the triglyceride-glucose index and risk of cardiovascular diseases and mortality in the general population: a systematic review and meta-analysis. Cardiovascular Diabetology. 21(1). 124–124. 209 indexed citations breakdown →
9.
Tan, Ziqi, Shanshan Huang, Menglu Liu, et al.. (2022). Relationship between serum growth differentiation factor 15, fibroblast growth factor-23 and risk of atrial fibrillation: A systematic review and meta-analysis. Frontiers in Cardiovascular Medicine. 9. 899667–899667. 11 indexed citations
10.
Tan, Ziqi, Shan Huang, Menglu Liu, et al.. (2022). The Prevalence and Associated Death of Ventricular Arrhythmia and Sudden Cardiac Death in Hospitalized Patients With COVID-19: A Systematic Review and Meta-Analysis. Frontiers in Cardiovascular Medicine. 8. 795750–795750. 18 indexed citations
11.
Liu, Menglu, Panpan Xia, Ziqi Tan, et al.. (2022). Fibroblast growth factor-23 and the risk of cardiovascular diseases and mortality in the general population: A systematic review and dose-response meta-analysis. Frontiers in Cardiovascular Medicine. 9. 989574–989574. 14 indexed citations
12.
Yu, Peng, Ziqi Tan, Zhangwang Li, et al.. (2022). Obesity and clinical outcomes in COVID-19 patients without comorbidities, a post-hoc analysis from ORCHID trial. Frontiers in Endocrinology. 13. 936976–936976. 2 indexed citations
14.
Tan, Ziqi, et al.. (2020). [Cardiac manifestations of patients with COVID-19 pneumonia and related treatment recommendations].. PubMed. 48(0). E005–E005. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026